These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. Ressler KJ; Rothbaum BO; Tannenbaum L; Anderson P; Graap K; Zimand E; Hodges L; Davis M Arch Gen Psychiatry; 2004 Nov; 61(11):1136-44. PubMed ID: 15520361 [TBL] [Abstract][Full Text] [Related]
3. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder. Hofmann SG; Meuret AE; Smits JA; Simon NM; Pollack MH; Eisenmenger K; Shiekh M; Otto MW Arch Gen Psychiatry; 2006 Mar; 63(3):298-304. PubMed ID: 16520435 [TBL] [Abstract][Full Text] [Related]
4. Facilitation of fear extinction in phobic participants with a novel cognitive enhancer: a randomized placebo controlled trial of yohimbine augmentation. Powers MB; Smits JA; Otto MW; Sanders C; Emmelkamp PM J Anxiety Disord; 2009 Apr; 23(3):350-6. PubMed ID: 19223151 [TBL] [Abstract][Full Text] [Related]
6. Treatment of pruritus with topically applied opiate receptor antagonist. Bigliardi PL; Stammer H; Jost G; Rufli T; Büchner S; Bigliardi-Qi M J Am Acad Dermatol; 2007 Jun; 56(6):979-88. PubMed ID: 17320241 [TBL] [Abstract][Full Text] [Related]
7. A randomized control trial of group counseling in a naltrexone treatment program. Tucker T; Ritter A; Maher C; Jackson H J Subst Abuse Treat; 2004 Dec; 27(4):277-88. PubMed ID: 15610829 [TBL] [Abstract][Full Text] [Related]
8. Naltrexone as a treatment for repetitive self-injurious behaviour:an open-label trial. Roth AS; Ostroff RB; Hoffman RE J Clin Psychiatry; 1996 Jun; 57(6):233-7. PubMed ID: 8666558 [TBL] [Abstract][Full Text] [Related]
9. A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, in the treatment of kleptomania. Grant JE; Kim SW; Odlaug BL Biol Psychiatry; 2009 Apr; 65(7):600-6. PubMed ID: 19217077 [TBL] [Abstract][Full Text] [Related]
10. Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial. O'Malley SS; Sinha R; Grilo CM; Capone C; Farren CK; McKee SA; Rounsaville BJ; Wu R Alcohol Clin Exp Res; 2007 Apr; 31(4):625-34. PubMed ID: 17374042 [TBL] [Abstract][Full Text] [Related]
11. Opioid antagonists in the treatment of impulse-control disorders. Kim SW J Clin Psychiatry; 1998 Apr; 59(4):159-64. PubMed ID: 9590665 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of oral naltrexone on pruritus in atopic eczema: a double-blind, placebo-controlled study. Malekzad F; Arbabi M; Mohtasham N; Toosi P; Jaberian M; Mohajer M; Mohammadi MR; Roodsari MR; Nasiri S J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):948-50. PubMed ID: 19453814 [TBL] [Abstract][Full Text] [Related]
13. A pilot study to assess the impact of naltrexone implant on accidental opiate overdose in 'high-risk' adolescent heroin users. Hulse GK; Tait RJ Addict Biol; 2003 Sep; 8(3):337-42. PubMed ID: 13129836 [TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear. Guastella AJ; Dadds MR; Lovibond PF; Mitchell P; Richardson R J Psychiatr Res; 2007 Sep; 41(6):466-71. PubMed ID: 16828803 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of naltrexone in smoking cessation: a preliminary study and an examination of sex differences. King A; de Wit H; Riley RC; Cao D; Niaura R; Hatsukami D Nicotine Tob Res; 2006 Oct; 8(5):671-82. PubMed ID: 17008194 [TBL] [Abstract][Full Text] [Related]
16. Cognitive-behavioral treatment for specific phobias with a child demonstrating severe problem behavior and developmental delays. Davis TE; Kurtz PF; Gardner AW; Carman NB Res Dev Disabil; 2007; 28(6):546-58. PubMed ID: 16950598 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of maintenance treatment with naltrexone for opioid dependence: a meta-analytical review. Johansson BA; Berglund M; Lindgren A Addiction; 2006 Apr; 101(4):491-503. PubMed ID: 16548929 [TBL] [Abstract][Full Text] [Related]
18. The role of imagery in the maintenance and treatment of snake fear. Hunt M; Bylsma L; Brock J; Fenton M; Goldberg A; Miller R; Tran T; Urgelles J J Behav Ther Exp Psychiatry; 2006 Dec; 37(4):283-98. PubMed ID: 16473325 [TBL] [Abstract][Full Text] [Related]
19. Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone. Hulse GK; Morris N; Arnold-Reed D; Tait RJ Arch Gen Psychiatry; 2009 Oct; 66(10):1108-15. PubMed ID: 19805701 [TBL] [Abstract][Full Text] [Related]
20. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking. Pettinati HM; O'Brien CP; Rabinowitz AR; Wortman SP; Oslin DW; Kampman KM; Dackis CA J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]